Amgen

Close up shot of the target from a dart game
Biotech

Amgen, Zai say stomach cancer candidate hits phase 3 mark

Based on the interim results, Zai Lab—a biotech that holds certain rights to bemarituzumab—will prepare a regulatory submission in China.
Gabrielle Masson Jun 30, 2025 10:36am
positive negative up down good bad mixed

Amgen's ph. 3 MariTide studies will ramp up dosing to quell nausea

Jun 24, 2025 9:59am
finch canary cage free bird release

FDA lifts hold on Amgen's phase 1 obesity study

May 2, 2025 10:10am
Abstract modern white spiral clock dial with roman and arabic numerals

Lilly links lepodisiran to durably lower lipoprotein in phase 2

Mar 31, 2025 4:24am
rocket launch satellite space fly blast off

Amgen ignites Rocket program with wins in phase 3 eczema trials

Mar 10, 2025 5:48am
chop down cut tree chainsaw ax

Amgen, CytomX ax T-cell engager after assessing data, priorities

Mar 7, 2025 5:39am